Haloperidol versus chlorpromazine for treatment of schizophrenia
- PMID: 18658127
- PMCID: PMC2632477
- DOI: 10.1093/schbul/sbn087
Haloperidol versus chlorpromazine for treatment of schizophrenia
Figures
References
-
- Adams CE, Awad G, Rathbone J. Chlorpromazine versus placebo for schizophrenia. Cochrane Database Syst Rev. 2007;(2) doi:10.1002/14651858.CD000284. - PubMed
-
- Joy CB, Adams CE, Laurie S. Haloperidol versus placebo for schizophrenia. Cochrane Database Syst Rev. 2006;(4) doi: 10.1002/14651858.CD003082. - PubMed
-
- Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry. 2003;60:553–564. - PubMed
-
- Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209–1223. - PubMed
-
- Jones PB, Barnes TRE, Davies L, et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia—cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1) Arch Gen Psychiatry. 2006;63:1079–1086. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
